EMA: A differentiation antigen related to node metastatic capacity of breast carcinomas

Pathology Research and Practice

Volumn 197, Issue 6, 2001, Pages 419-425

  Luna Moré, Sebastián ^a   Rius, Francisca ^b,c   Weil, Bernardo ^a   Jimenez, Ana ^a   Bautista, Maria Dolores ^a   Pérez Mellado, Alfonso ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b UNIVERSIDAD DE MÁLAGA   (Spain)

^c Servicio de Anatomiacute   (Spain)

Author keywords

Breast neoplasms; EMA; MUC1; Node metastasis

Indexed keywords

DIFFERENTIATION ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; ESTROGEN RECEPTOR; GLYCOPROTEIN; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST DUCT; CANCER CELL; CANCER CLASSIFICATION; CANCER GRADING; CANCER SIZE; CANCER SURVIVAL; CELL MEMBRANE; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREDICTION; PROBABILITY; PROTEIN LOCALIZATION; REGRESSION ANALYSIS; STAINING; STATISTICAL ANALYSIS;

EID: 0034969487     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00055     Document Type: Article

References (35)

1. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2
2. Survival in breast cancer related to tumour oestrogen receptor status and immunohistochemical staining for NCRC11
3. The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer
4. An evaluation of the usefulness of primary tumour expression of MCA and CA15-3 as prognostic indicators in breast carcinoma
5. Levels of expression of breast epithelia mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis
6. Epithelial membrane antigen in hematolymphoid neoplasms
7. Mucins: Structure, function, and association with malignancy
8. A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterization
9. Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC11: A new prognostic indicator
10. Evaluation of immunoreactivity with monoclonal antibody NCRC11 in breast carcinoma
11. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
12. Comparison of tissue polypeptide antigen (TPA) with cancer antigen 15-3 (CA 15-3) and carcinoembryonic antigen (CEA) in follow-up of breast cancer
13. The Nottingham Prognostic Index in primary breast cancer
14. Prediction of prognosis in primary breast cancer by detection of a high molecular weight mucin-like antigen using monoclonal antibodies DF3, F36/22, and CU18: A Cancer and Leukemia Group B study
15. A new monoclonal antibody to epithelial membrane antigen (EMA) - E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2
16. Cell membrane-associated mucins and their adhesion-modulating property
17. Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines
18. The value of tissue polypeptide specific antigen TPS determination in serum of women with breast cancer: Comparison to mucin-like associated antigen MCA and CA 15-3
19. Suppression of cellular aggregation by high levels of episialin
20. Invasive micropapillary carcinoma of the breast: A new special type of invasive mammary carcinoma
21. Estrogen and progesterone receptors, C-erbB-2, p53, and BCL-2 in thirty-three invasive micropapillary breast carcinomas
22. Importance of oestrogen receptors on the behaviour of invasive micropapillary carcinoma of the breast. Review of sixty-eight cases with follow-up of fifty-four
23. Prognostic significance of MUC1 epithelial mucin expression in breast cancer
24. Progesterone stimulates production and secretion of MUC1 epithelial mucin in steroid-responsive breast cancer cell-lines
25. CEA, and CA 15.3 in patients with breast cancer: Prognostic value
26. Topographic criteria in the diagnosis of tumor emboli in intramammary lymphatics
27. Quantitation of human milk fat globule (HMFG1) expression in breast carcinoma and its association with survival
28. Invasive micropapillary carcinoma of the breast: A prognostic study
29. The epithelial mucin, MUC1, of milk, mammary gland and other tissues
30. The epithelial mucin MUC1 contains at least two discrete signals specifying membrane localization in cells
31. Breast cancer associated mucin: A review
32. Hormonal regulation of MUC1 expression
33. Assessment of milk fat globule membrane antibodies and lectins as markers of short-term prognosis in breast cancer
34. The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas
35. Prognostic factors in breast cancer: Immunohistochemical staining for SP1 and NCRC 11 related to survival, tumour epidermal growth factor receptor and oestrogen receptor status